Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Immune checkpoint inhibitors; Immune-related adverse events; Drug induced liver injury; Autoimmune hepatitis;
مقالات ISI مواد مخدر آسیب کبدی را ایجاد می کند (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; ALT; Alanine Aminotransferase; AST; Aspartate Aminotransferase; BMT; Bone Marrow Transplantation; DAA; Direct-Acting Antiviral; DILI; Drug Induced Liver Injury; GVHD; Graft Versus Host Disease; HAI; Hepatic Activity Index; HCV; Hepatitis C Virus; MRI; Mag
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; ADME; absorption, distribution, metabolism and excretion; AFND; allele frequency net database; ALT; alanine aminotransferase; AOP; adverse outcome pathway; AOP-KB; AOP knowledge base; AST; aspartate aminotransferase; BSEP; bile salt export protein; CAR; c
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Drug Induced Liver Injury; Drug Induced Liver Injury Network; Significant Alcohol Consumption; RUCAM; Chronic DILI; ALT; alanine aminotransferase; DILI; drug-induced liver injury; DILIN; Drug-induced Liver Injury Network; INR; international normalized rat
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Incidence; Drug induced liver injury; Antitubercular therapy; Antiretroviral therapy; HIV positive;
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Anti-tubercular treatment; Drug induced liver injury; Liver function tests;
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; DILI; drug induced liver injury; hES-HLCs; hepatocyte-like cells derived from human embryonic stem cells; APAP; acetaminophen; TZD; thiazolidinedione; TNF; tumor necrosis factor; ÎL; interleukin; IFN; interferon; PHHs; primary human hepatocytes; hES-DE;
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; ALT; alanine aminotransferase; AST; aspartate aminotransferase; DILI; drug induced liver injury; AILI; amiodarone induced liver injury; ULN; upper limit of normal; CM; cardiomyopathy; Intravenous amiodarone; Parenteral amiodarone; Liver injury; Drug induc
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Drug induced liver injury; DILI; Liver biomarker; In vitro hepatocytes; Computational modeling; Hy's law;
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Acute liver failure; Drug induced liver injury; Interferon β; Multiple sclerosis;
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Idiosyncratic hepatotoxicity; Oxidative stress; Reactive metabolites; Adverse drug reactions; Drug induced liver injury; DILI
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; DILI; drug induced liver injury; FDA; Food and Drug Administration; NIH; National Institute of Health; LTKB; Liver Toxicity Knowledge Base; QSAR; quantitative structure activity relationship; ADME; absorption, distribution, metabolism and excretion; ALT;
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; ACAT; acyl-CoA cholesterol acyltransferase; ACC; acetyl CoA carboxylases; ACLY; ATP citrate lyases; ACSL; acyl CoA synthetases long chain family; ADRP; adipose differentiation related protein; AGP; advanced glycation end products; AGPAT; acylglycerophosph
Hepatoprotective effect of lawsone on rifampicin-isoniazid induced hepatotoxicity in in vitro and in vivo models
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Naphthoquinones; Lawsone; Liver; Anti-oxidants; Transaminases; Tuberculosis; Drug induced liver injury;
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; AASLD; American Association for the Study of Liver Diseases; ADV; adefovir dipivoxil; ALT; alanine aminotransferase; Anti-HBe; antibodies to hepatitis B envelope antigen; anti-HBs; antibody to hepatitis B surface antigen; APASL; Asian Pacific Association
Acute liver injury induced by levetiracetam and temozolomide co-treatment
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Drug induced liver injury; Levetiracetam; Temozolomide;
Flupirtine associated acute liver failure- case from India and review of literature
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; flupirtine; fulminant hepatic failure; drug induced liver injury; ALF; plasmapheresis; CRRT;
Case ReportBupivacaine drug-induced liver injury: a case series and brief review of the literature
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Analgesics; Cholestasis; Bupivacaine; Drug induced liver injury;
Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Buprenorphine; HIV; Hepatitis C; Drug induced liver injury;
Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Drug induced liver injury; Acute liver failure; Oxidative stress; In vitro toxicity testing; Human hepatocytes; Drug development
Mitochondrial toxicity of diclofenac and its metabolites via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria: Possible role in drug induced liver injury (DILI)
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Oxidative phosphorylation; ATP; Drug induced liver injury; Rat liver mitochondria; Diclofenac; Metabolites;
Mitochondrial toxicity of selective COX-2 inhibitors via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Drug induced liver injury; Selective COX-2 inhibitors; Rat liver mitochondria; Oxidative phosphorylation; ATP; In vitro metabolism;
Research ArticleProtective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; AHB; acute hepatitis B; ALT; alanine aminotransferase; AIH; autoimmune hepatitis; CHB; chronic hepatitis B; CK 7; cytokeratin 7; DILI; drug induced liver injury; HAI; histological activity index; IL-22; interleukin-22; IL-17; interleukin-17; NSAIDs; non-s
Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; miRNA; microRNA; DILI; drug induced liver injury; APAP; acetaminophen; ALT; alanine aminotransferase; ALF; acute liver failure; Acetaminophen; Pediatric; Urine; MicroRNA; DILI;
Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBaseâ¢
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; ACEI; angiotensin converting enzyme inhibitor; ADE; adverse drug events; AERS; adverse event reporting system; APAP; acetaminophen; ATC classification; Anatomical Therapeutic Chemical Classification; ATIIA; angiotensin II receptor antagonist; BSEP; bile s
Research ArticleCHOP is a critical regulator of acetaminophen-induced hepatotoxicity
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; DILI; drug induced liver injury; APAP; acetaminophen (N-acetyl-p-aminophenol); NAPQI; N-acetylbenzoquinoneimine; GSH; glutathione; ER; endoplasmic reticulum; UPR; unfolded protein response; ALI; acute liver injury; ROS; reactive oxygen species; ALT; alani
BSEP inhibition – In vitro screens to assess cholestatic potential of drugs
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; TC, taurocholate; GC, glycocholate; TCDC, taurochenodeoxycholate; GCDC, glycochenodeoxycholateBSEP; Transporter; Bile salt; Drug induced liver injury; Cholestasis; Toxicity
A pre-marketing ALT signal predicts post-marketing liver safety
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; DILI; drug induced liver injury; FDA; Food and Drug Administration; AERS; Adverse Event Reporting System; ALT; alanine aminotransferase; ULN; upper limit of normal; NDA; new drug application; EMA; European Medicines Agency; PDR; Physician's Desk Referen
Thalidomide-induced acute cholestatic hepatitis: Case report and review of the literature
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Thalidomide; Multiple myeloma; Drug induced liver injury; Talidomida; Mieloma múltiple; Lesión hepática inducida por medicamentos;
Hepatitis colestásica por amoxicilina
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Hepatotoxicidad farmacológica; Amoxicilina; Drug induced liver injury; Amoxicillin;
Herbal hepatotoxicity by kava: Update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Drug induced liver injury; Herbal hepatotoxicity; Herbs induced liver injury; Kava; Kava hepatotoxicity; Piper methysticum
Research ArticleRecurrent Drug-Induced Liver Injury (DILI) with different drugs in the Spanish Registry: The dilemma of the relationship to autoimmune hepatitis
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; ALT; alanine aminotransferase; ALP; alkaline phosphatase; DILI; drug induced idiosyncratic liver injury; CIOMS; Council for International Organizations of Medical Science; Drug induced liver injury; Hepatotoxicity; Second DILI episode; Rechallenge; Class
Kava hepatotoxicity solution: A six-point plan for new kava standardization
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; Kava; Piper methysticum; Kava hepatotoxicity; Herbal hepatotoxicity; Drug induced liver injury; Herbs induced liver injury; Kava regulation;
Ximelagatran increases membrane fluidity and changes membrane lipid composition in primary human hepatocytes
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; ALT, alanine transferase; LDH, lactate dehydrogenase; EPR, Electron Paramagnetic Resonance; PC, phosphatidylcholine; PE, phosphatidylethanolamine; S/P, saturated versus polyunsaturated fatty acidsMembrane fluidity; Drug induced liver injury; Lipid composi
Drugs that damage the liver
Keywords: مواد مخدر آسیب کبدی را ایجاد می کند; adverse drug reactions; cholestatic hepatitis; drug induced liver injury; drug metabolism; paracetamol toxicity; steatosis